NCT04294004 - KUR-113 Bone Graft Versus Local Autograft for the Treatment of Single-level Transforaminal Lumbar Interbody Fusion | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 27, 2020

Primary Completion Date

July 30, 2024

Study Completion Date

July 30, 2025

Conditions

Degenerative Disc DiseaseSpinal Fusion

Interventions

COMBINATION_PRODUCT

TGplPTH1-34 in fibrin

TGplPTH1-34 within a fibrin matrix applied within and around a polyetheretherketone (PEEK) intervertebral cage

OTHER

Autologous Bone Graft

Local autograft collected from decompression which may be supplemented with iliac crest bone graft (ICBG) if local autograft is insufficient.

Trial Locations (15)

10021

Hospital for Special Surgery, New York

14221

University at Buffalo Neurosurgery, Williamsville

15212

Allegheny General Hospital, Pittsburgh

19104

Hospital of the University of Pennsylvania, Philadelphia

20007

MedStar Georgetown University Hospital, Washington D.C.

46032

Indiana Spine Group, Carmel

49525

Orthopedic Associates of Michigan, Grand Rapids

60611

Northwestern University-Northwestern Memorial Hospital, Chicago

63110

Washington University in St. Louis, St Louis

67226

Kansas Spine and Specialty Hospital, Wichita

78229

University of Texas Health Science Center at San Antonio, San Antonio

78240

South Texas Spine Center, San Antonio

80303

Justin Parker Neurological Institute, Boulder

92093-0863

University of California San Diego, La Jolla

02115

Brigham and Women's Hospital, Boston